Recent Finacing
Recent Raise
Akroswiss develops a patented Midazolam-based bi-dose nasal spray and 360° delivery device for claustrophobia premedication during procedures and emergency intranasal seizure rescue, pursuing EMA-aligned clinical and device regulatory approvals.